Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial
Anne-Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H M Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie-Cécile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R van Rijn, Keith Wheatley, Véronique Minard-Colin, Julia C Chisholm
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
42Citaten
(Scopus)
Vingerafdruk
Duik in de onderzoeksthema's van 'Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial'. Samen vormen ze een unieke vingerafdruk.